Sucrose stearate as a biosurfactant for development of rivastigmine containing nanostructured lipid carriers and assessment of its activity against dementia in C. elegans model-Reference-Cited by-同舟云学术

Sucrose stearate as a biosurfactant for development of rivastigmine containing nanostructured lipid carriers and assessment of its activity against dementia in C. elegans model

Published:2019-02 Issue: Volume:49 Page:219-226
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Anand Anubhav,Arya Malti,Kaithwas Gaurav,Singh Gyanendra,Saraf Shubhini A.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference25 articles.

1. Controlled release of huperzine A from biodegradable microspheres: in vitro and in vivo studies;Gao;Int. J. Pharm.,2007

2. Treatment of dementia with neurotransmission modulation;Doggrell;Expet Opin. Invest. Drugs,2003

3. Rivastigmine in the treatment of Alzheimer's disease: an update;Onor;Clin. Interv. Aging,2007

4. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors;Jann;Clin. Pharmacokinet.,2002

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems;AAPS PharmSciTech;2024-09-05

2. QbD-based optimization and evaluation of chitosan-adorned nanostructured lipid carriers for nose-to-brain delivery of 17β-Estradiol in rat model of Alzheimer's disease;Journal of Drug Delivery Science and Technology;2024-06

3. Design, Fabrication, In-vitro, and Ex-Vivo Permeation Study Nisoldipine (NSP) Loaded SLNs by Modified Solvent Diffusion Method;Research Journal of Pharmacy and Technology;2024-05-15

4. Forecasting the Parallel Interaction between Biosurfactants and Neurons: A Challenge for Clinicians;Biosurfactants: A Boon to Healthcare, Agriculture & Environmental Sustainability;2024-03-04

5. Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway;RSC Pharmaceutics;2024